MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Autonomic dysfunction"

  • 2017 International Congress

    The FDA is listening: Integrating the voice of the patient in drug development for Parkinson’s and Huntington’s diseases.

    D. Stephenson, A. Porter, K. Romero, G. Podskalny, E. Bastings, B. Dunn, S. Goldstein, T. Mullin (Tucson, AZ, USA)

    Objective: To present highlights from the Patient-Focused Drug Development (PFDD) meetings held at FDA for Parkinson’s disease (PD) and Huntington’s disease (HD) to raise awareness…
  • 2017 International Congress

    Pancreatic polypeptide plasma levels in Parkinson’s disease – a marker of parasympathetic denervation

    K. Knudsen, T. Fedorova, K. Østergaard, P. Borghammer (Aarhus, Denmark)

    Objective: To study plasma PP concentration during sham feeding in PD patients and healthy controls, as a measure of pancreatic vagal innervation. Background: Most patients…
  • 2017 International Congress

    Neurogenic Orthostatic Hypotension Burden of Illness Patient and Caregiver Survey: Impact of Symptoms

    D. Claassen, C. Adler, C. Gibbons, L.A. Hewitt (Nashville, TN, USA)

    Objective: To determine the impact of neurogenic orthostatic hypotension (nOH) on the quality of life (QoL) of patients with autonomic dysfunction and the burden on…
  • 2017 International Congress

    Heart rate variability in Parkinson’s Disease and idiopathic REM sleep behavior disorder and relation with other non-motor symptoms

    P. Bugalho, M. Mendonça, T. Lampreia, R. Miguel, R. Barbosa, M. Salavisa (Lisbon, Portugal)

    Objective: To evaluate Heart Rate Variability (HRV) changes across sleep stages in Parkinson's Disease (PD) and idiopathic REM Sleep Behavior disorder (RBD) patients, and to…
  • 2017 International Congress

    Patient-Reported Outcomes in a Prospective Real-World Study of Droxidopa for the Treatment of Neurogenic Orthostatic Hypotension

    S. Kymes, C. François, K. McLeod, A. Duhig, A. Ogbonnaya, A. Quillen, J. Cannon, C. Shibao, B. Yue, I. Biaggioni (Deerfield, IL, USA)

    Objective: To assess the effect of droxidopa treatment on function, depression, and health-related quality of life (HRQoL) in patients with neurogenic orthostatic hypotension (nOH). Background:…
  • 2017 International Congress

    Assessment of Autonomic Dysfunction in Parkinson’s Disease

    K. Karbozova, , (Bishkek, Kyrgyzstan)

    Objective: Assessment of autonomic dysfunction in patients with Parkinson's disease and further comparison with patients without autonomic symptoms Background: A frequent disabling complication of Parkinson’s…
  • 2017 International Congress

    Combined Surgical Therapies for Optimal Management of Advanced Parkinson’s Disease

    L. Kirkpatrick, Y. Torres-Yaghi, A. Keys, N. Starr, T. Kimbason, C. Moussa, F. Amjad, F. Pagan (Washington, DC, USA)

    Objective: We report a case of a patient with advanced PD who began LCIG for refractory motor fluctuations while continuing longstanding STN-DBS. Background: LCIG and…
  • 2017 International Congress

    Association of impaired melatonin secretion with sleep disturbance in Parkinson’s disease

    T. Nakamura, M. Suzuki, M. Ueda, E. Imai, G. Tohnai, M. Katsuno (Nagoya, Japan)

    Objective: To clarify if impaired melatonin secretion is associated with daytime or nighttime sleep disturbances in patients with Parkinson’s disease (PD). Background: PD is associated…
  • 2017 International Congress

    Listen to your heart: ordinal pattern statistics reveal altered cardiac rhythm dynamics in LRRK2-nonmanifesting carriers

    C. Carricarte Naranjo, C. Marras, N. Visanji, A. Lang, L. Sanchez-Rodriguez, A. Machado García (La Habana, Cuba)

    Objective: To assess the complexity of heart rate variability (HRV) dynamics in LRRK2-nonmanifesting carriers compared to healthy individuals. Background: Cardiovascular autonomic dysfunction is an early…
  • 2017 International Congress

    Real-world non-motor score changes in Parkinson’s disease patients with motor fluctuations: The J-FIRST study

    H. Watanabe, H. Saiki, S.-W. Chiu, T. Yamaguchi, K. Kashihara, Y. Tsuboi, M. Nomoto, N. Hattori, T. Maeda, Y. Shimo (Nagoya, Japan)

    Objective: To identify changes in non-motor symptoms (NMSs) over time in Japanese Parkinson’s disease (PD) patients without dementia exhibiting motor fluctuations. Background: PD can cause…
  • « Previous Page
  • 1
  • …
  • 21
  • 22
  • 23
  • 24
  • 25
  • …
  • 27
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley